Athyrium Opportunities 2020 LP 13D/13G Filings for Biora Therapeutics, Inc. (BIOR)

Athyrium Opportunities 2020 LP 13D and 13G filings for Biora Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-04-02
8:43 pm
Purchase
2024-03-3113DBiora Therapeutics, Inc.
BIOR
Athyrium Opportunities 2020 LP1,930,628
49.900%
309,176increase
(+19.07%)
Filing
2023-12-20
4:35 pm
Purchase
2023-12-1813DBiora Therapeutics, Inc.
BIOR
Athyrium Opportunities 2020 LP1,621,453
49.900%
386,569increase
(+31.30%)
Filing
2023-09-19
4:15 pm
Purchase
2023-09-1813DBiora Therapeutics, Inc.
BIOR
Athyrium Opportunities 2020 LP1,234,884
49.900%
867,926increase
(+236.52%)
Filing
2023-03-13
4:18 pm
Purchase
2023-03-1013DBiora Therapeutics, Inc.
BIOR
Athyrium Opportunities 2020 LP366,958
32.700%
82,414increase
(+28.96%)
Filing
2023-01-12
4:46 pm
Purchase
2023-01-0313DBiora Therapeutics, Inc.
BIOR
Athyrium Opportunities 2020 LP284,544
27.800%
0increase
(+0.00%)
Filing
2022-11-18
4:30 pm
Purchase
2022-11-0913DBiora Therapeutics, Inc.
BIOR
Athyrium Opportunities 2020 LP284,544
28.400%
16,036increase
(+5.97%)
Filing
2021-11-26
4:45 pm
Purchase
2021-11-2413DBiora Therapeutics, Inc.
BIOR
Athyrium Opportunities 2020 LP268,509
31.100%
268,509increase
(New Position)
Filing